anmelden
SPI
18.684,24
PKT
+101,75
PKT
+0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.11.17 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 16.11.17 | Roche buy | Jefferies & Company Inc. | |
| 15.11.17 | Peach Property Group Kaufen | SRC Research GmbH | |
| 16.11.17 | UBS buy | HSBC | |
| 16.11.17 | Zurich Insurance Neutral | UBS AG | |
| 16.11.17 | UBS Underperform | Macquarie Research | |
| 16.11.17 | UBS Neutral | Macquarie Research | |
| 15.11.17 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.11.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 14.11.17 | Novartis overweight | Morgan Stanley | |
| 13.11.17 | Zurich Insurance Equal-Weight | Morgan Stanley | |
| 10.11.17 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
| 10.11.17 | UBS buy | Merrill Lynch & Co., Inc. | |
| 09.11.17 | Zurich Insurance Neutral | UBS AG | |
| 09.11.17 | Zurich Insurance Hold | S&P Capital IQ | |
| 09.11.17 | Givaudan neutral | Bernstein Research | |
| 09.11.17 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 09.11.17 | Zurich Insurance Underperform | Bernstein Research | |
| 08.11.17 | Novartis Hold | Deutsche Bank AG | |
| 08.11.17 | UBS buy | Citigroup Corp. | |
| 08.11.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 07.11.17 | Zurich Insurance Neutral | UBS AG | |
| 07.11.17 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 07.11.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 07.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.17 | Zurich Insurance Hold | Deutsche Bank AG | |
| 06.11.17 | Swiss Re overweight | Morgan Stanley | |
| 06.11.17 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 06.11.17 | Roche overweight | JP Morgan Chase & Co. | |
| 06.11.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 03.11.17 | UBS buy | Goldman Sachs Group Inc. | |
| 03.11.17 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 03.11.17 | UBS overweight | Morgan Stanley | |
| 03.11.17 | UBS Hold | S&P Capital IQ | |
| 03.11.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 03.11.17 | UBS kaufen | JP Morgan Chase & Co. | |
| 02.11.17 | Swiss Re kaufen | DZ BANK | |
| 02.11.17 | UBS buy | UBS AG | |
| 02.11.17 | Novartis Neutral | JP Morgan Chase & Co. |